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The vascular endothelium is best known for its role in oxygen and nutrient delivery to the various
tissues. Growing evidence supports a far more complex role in tissue homeostasis. In particular, re-
ciprocal interactions between endothelial cells and the local microenvironment may regulate organ
development and pattern formation. Such interactions appear to be important also in the adult, in
normal and pathological conditions.Introduction
In multicellular organisms, vascular tissue is necessary to
establish a circulation that delivers nutrients and oxygen,
removes waste products, and provides a means for inter-
organ communication (Risau, 1997). In animals, the vas-
culature is comprised of blood vessels, which permeate
most tissues to ensure sufficient oxygen diffusion. Blood
vessels are lined by a specialized cell type called endothe-
lial cells, and, given their ubiquitous presence, it is not sur-
prising that they have evolved functions beyond nutrient
and oxygen transport. In recent years, significant progress
has been made in describing the reciprocal relationship
between the endothelial compartment and its surrounding
microenvironment. It is now apparent that endothelial cells
provide inductive signals during organ development as
well as cell guidance molecules involved in patterning.
Conversely, the vasculature responds to cues from the
parenchyma that bestow upon it tissue-specific functions.
Similar signals function under pathological conditions,
where endothelial cells play a critical role in defining the
local immune response and provide support for tumor
growth. Given their vital importance to tissue survival,
many of these mechanisms are being targeted in hopes
of limiting tumor growth and ameliorating destructive in-
flammatory diseases. In this review, we discuss the major
advances leading to the current understanding of how
endothelial cell interactions may influence development
and the adult state. We first focus on relevant advances
in vasculogenesis/angiogenesis and the reciprocal signals
that function during this process. Then, the mechanisms
by which endothelial cells influence organogenesis are
highlighted with a final discussion on their relation to
pathophysiology, particularly tumorigenesis.
Vascular Morphogenesis
Formation of the cardiovascular system is one of the ear-
liest events to occur during embryonic development.
Much is known about the genetic requirements during
this process, principally involving receptor tyrosine ki-
nases and their ligands, including the following receptor-
ligand pairs: VEGF-A/VEGFR-1 and -2, Ang1/Tie2, andDephrinB2/EphB4 (reviewed in Coultas et al., 2005; Ferrara
and Kerbel, 2005).
Vascular development begins when cells of mesenchy-
mal origin within the embryo differentiate into multipotent
angioblasts, which are believed to arise from the heman-
gioblast, a common precursor for endothelial and hemato-
poietic lineages. These cells undergo vasculogenesis
where they aggregate and form a primitive vascular net-
work de novo (Risau, 1997). Subsequent signaling events
stimulatedby the surrounding environment, hemodynamic
forces, and the endothelium itself trigger the complex pro-
cess of vascular remodeling (reviewed in Carmeliet, 2003;
Ferrara and Kerbel, 2005). Extensive pruning, angiogene-
sis (outgrowth from preformed vessels), and investment
with extravascular cell types results in the formation of
a mature vessel network containing arterial, capillary,
and venous components, each ofwhich canbe associated
with different types and amounts of peri-vascular support
cells aswell asdevelop tissue-specific functions (Figure 1).
The morphogenic events that occur during vasculogen-
esis/angiogenesis are not thoroughly understood, but
current efforts in zebrafish are shedding new light on the
issue. As a result of multiple in vitro and genetic observa-
tions, hemangioblasts have been proposed to be the com-
mon precursor of hematopoietic and endothelial cell line-
ages (Eichmann et al., 2002). However, formal proof of
their existence in vivo has been lacking. Recent studies
have provided evidence for the presence of hemangio-
blasts in vivo in zebrafish and reveal some surprising prop-
erties of these progenitors (Vogeli et al., 2006). Lineage-
tracing experiments that labeled single cells at the ventral
margin of the embryo at 1 hr post gastrulation could give
rise to a labeled population consisting exclusively of he-
matopoietic (gata-1-positive) and endothelial (Flk1-posi-
tive) lineages. Surprisingly, the hemangioblasts labeled
in these experiments did not contribute to all endothelial
cells. Instead, they produced a population that clusters
at specific regions of the axial vessels, which have been
proposed to be involved in hematopoiesis (Vogeli et al.,
2006). The fact that hemangioblasts may generate only a
specialized subset of vessels reveals a higher complexity
of compartmentalization during vascular development.evelopmental Cell 12, February 2007 ª2007 Elsevier Inc. 181
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Vasculature
The circulation is structured such that oxygen-
rich blood leaving the heart is delivered to dif-
ferent tissues through arterial vessels that are
invested with a significant layer of vascular
smooth muscle. Within the tissue, these ves-
sels branch into smaller capillaries capable of
mediating oxygen and nutrient exchange.
Capillaries are primarily associated with peri-
cytes and can develop tissue-specific char-
acteristics. For example, constitutive VEGF ex-
pression in certain endocrine glands promotes
a fenestrated (gapped) endothelial layer, while
astrocyte-derived TGFb and Ang-1 induces
tight junctions characteristic of the blood-brain
barrier. Following exchange, capillaries con-
verge, forming venous vessels that deliver de-
oxygenated blood back to the heart. In general,
veins are lower resistance and have larger lu-
mens than arteries, with a reduced amount of
vascular smooth muscle coverage.Interactions between endothelial cells and their sur-
rounding environment are critical for vascular maturation
(Figure 2). One component of this environment is the ex-
tracellular matrix (ECM), a scaffold of proteins secreted
and organized by cells including those of stromal and
endothelial origin. Blood vessels are encased in a special-
ized sleeve of ECM called the basement membrane (BM),
which provides structural support, serves as a substrate
for endothelial cell migration, and regulates pro- and anti-
angiogenic factors (Gerhardt and Betsholtz, 2003). The
importance of this structure is underscored by the vascu-
lar defects seen in mice deficient in various BM constitu-
ents such as type IV collagen and laminins (Davis and
Senger, 2005; Poschl et al., 2004; Thyboll et al., 2002). In-
terestingly, the BM can be pro- and antiangiogenic, often
using different cleavage products of the same protein
(Gerhardt and Betsholtz, 2003). For example, intact type
IV collagen promotes endothelial proliferation and migra-
tion through integrin a1b1 and a2b1 binding, whereas
degradation products bind avb3, inhibiting these same
processes (Nyberg et al., 2005). ECM cleavage can pro-
duce multiple antiangiogenic molecules that are detect-
able in the circulation, including arresten (a 26 kD fragment
of the NCI domain of type IV collagen a1), canstatin (a 24
kD fragment of type IV collagen a2 chain), tumstatin (a 28
kD fragment of type IV collagen a3 chain), and endostatin
(a 20–22 kD C-terminal fragment of the collagen type XVIII
a1chain) (reviewed in Nyberg et al., 2005). Mechanisti-
cally, tumstatin appears to be an endothelial-specific
protein synthesis inhibitor that, upon binding avb3 integ-
rin, inhibits focal adhesion kinase (FAK), phosphatidylino-
sitol 3-kinase (PI3-kinase), protein kinase B (PKB/Akt),
and mammalian target of rapamycin (mTOR), leading to
downregulation of CAP-dependent protein translation
(Maeshima et al., 2002). The role of these molecules dur-
ing development has not been well characterized, but
evidence suggests that they may be important regulators
in pathological conditions (see below).
To become stabilized and mature, vessels must recruit
and associate with support cells, including mural cells182 Developmental Cell 12, February 2007 ª2007 Elsevier Inc.(pericytes and vascular smooth muscle cells [vSMCs]).
These two cell types aremorphologically similar and share
the expression of several different markers, but differ in
their relationship to the endothelial cell layer (Gerhardt
and Betsholtz, 2003). vSMCs cover larger vessels and
have no direct contact with the endothelium, while peri-
cytes support smaller vessels and cross through holes in
the basement membrane to form tight and gap junctions
with endothelial cells. One pericyte may interact with
more than one endothelial cell (Simionescu and Simio-
nescu, 1988) and is thus able to integrate signals along
the length of the blood vessel.
As they mature, naked blood vessels attract pericytes
and vSMCs through PDGF-B. Mice deficient in either
PDGF-B (including an endothelial-specific conditional
knockout) or PDGFR-b lack mural cell coverage, leading
to endothelial hyperplasia, impaired endothelial differenti-
ation, edema, hemorrhage, and lethality (Lindahl et al.,
1997;Gerhardt andBetsholtz, 2003). Interactions between
PDGF-B and the ECM are essential. Vessels in mice that
harbor a deletion in the PDGF-B retention motif, which is
required for its association with the ECM, display defects
in pericyte investment (Lindblom et al., 2003). Metallopro-
teinases are also important, which, in the case of MMP-9,
are predominately produced by stromal and bone mar-
row-derived cells. Vessels in mice lacking MMP-9 and
MT1-MMP do not properly associate with mural cells,
while MT1-MMP null vSMCs exhibit defects in PDGF-B
responsiveness (Chantrain et al., 2004; Jodele et al.,
2005; Lehti et al., 2005). In addition to influencing mural
cell migration, endothelial cell-derived signals also trigger
their differentiation. This activity includes mechanisms
that required heterotypic cell-cell interactions between
the two populations and are partially dependent on TGF-
b (Ding et al., 2004; Hirschi et al., 2003).
Reciprocal signals also occur where mural cells influ-
ence endothelial function. For example, mural cells can re-
inforce the angiogenic response by producing VEGF-A to
stimulate endothelial growth (Reinmuth et al., 2001; Rey-
nolds et al., 2000). Conversely, pericytes are important
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Requires Numerous Interactions
between Endothelial Cells and the
Surrounding Environment
Stable vessels are invested bymural cells (peri-
cytes and/or vascular smooth muscle) that,
along with endothelial cells, secrete extracellu-
lar matrix (ECM) components that form the
vascular basement membrane (BM). Endothe-
lial cell-derived signals, including PDGF-B, are
critical for attracting mural cells to the vessel
wall and triggering their differentiation. In recip-
rocal interactions, mural cells can both posi-
tively (green) and negatively (red) affect endo-
thelial growth and development. These and
other accessory cell types, such as fibroblasts
and hematopoietic cells, actively participate in
angiogenesis. They produce angiogenic ECM
components and growth factors (VEGF) as
well as stimulate ECM remodeling through
MMP secretion. ECM cleavage can also yield
angiostatic fragments, underscoring the com-
plex balance between pro- and antiangiogenic
factors during vascular remodeling.sources of restrictive signals, as evidenced by the pres-
ence of endothelial hyperplasia in PDGF-B and PDGFR-
b null mice (Hellstrom et al., 2001). Pericytes, vSMCs,
and the surrounding mesenchyme produce angiopoietin-
1 (Ang-1), which binds the tyrosine kinase receptor,
Tie2, expressed on endothelial cells, resulting in enhanced
endothelial-mural cell interactions, possibly through the
induction of hepatocyte growth factor (HGF) (Kobayashi
et al., 2006; Sato et al., 1995; Suri et al., 1996). A homolog,
Ang-2, appears to antagonize Ang-1, at least in some
settings, relaxing these interactions and triggering BM
degradation in preparation for angiogenic cell migration
(Maisonpierre et al., 1997). Several other molecules, in-
cluding VCAM, a4b1 integrin, and sphingosine-1-phos-
phate (SIP) and its receptor, SIP1, are involved in mural
cell recruitment and/or vessel stabilization (von Tell
et al., 2006).
Elaboration of the vessel structure during angiogenesis
involves coordinated attractive and repulsive guidance
cues. As this is similar to axon pathfinding during neural
development, it is not surprising that guidance molecules
are shared between the two systems, specifically the re-
ceptor-ligand pairs Eph/ephrin, semaphorin/neuropilin/
plexin, netrin/UNC, and Slit/Robo (Eichmann et al.,
2005). Further intertwining of these pathways occurs
when VEGF-A uses the semaphorin receptor, neuropilin-
1. Surprisingly, neuropilin-1 was found to be a coreceptor
that selectively interacts with the heparin-binding VEGF
isoforms and enhances the effectiveness of VEGFR2-me-
diated signaling (Soker et al., 1998). A widely used system
for studying vascular guidance mechanisms has been the
angiogenesis that occurs within the developing somites.
During embryonic development, vessels sprout from the
dorsal aorta and grow dorsally in an intersomitic distribu-
tion. This pattern can be disrupted, causing ectopic vessel
sprouting, by deletion of multiple repulsive cues ex-
pressed within the somites, including ephrinB molecules
(Adams et al., 1999; Gerety et al., 1999; Helbling et al.,
2000) and semaphorin3E (Gitler et al., 2004; Gu et al.,D2005; Torres-Vazquez et al., 2004). Disruption of the ne-
trin1a/UNC5b axis similarly affects intersomitic sprouting
(Lu et al., 2004). These observations, coupled with exper-
iments showing tip cell or filapodia retraction upon treat-
ment with these factors, establish their role as repulsive
guidance molecules during angiogenesis.
A recent report attributes an attractive function to
netrin1a during vascular remodeling, which was in an
UNC5b-independent fashion (Wilson et al., 2006). Also,
netrin1 was found to stimulate angiogenesis in various in
vivo models (Park et al., 2004). In addition, application of
netrin-1 or -4 increased vascular recovery in a model of
hindlimb ischemia to levels at or above those stimulated
by VEGF (Wilson et al., 2006). These observations conflict
with the above mentioned studies describing netrins as
potential repulsive signals for the vasculature (Lu et al.,
2004), although the basis of this discrepancy is not cur-
rently understood.
Developmental Signals that Direct
Artery-Vein Specification
Observations made by anatomists hundreds of years ago
recognized that the arterial and venous sides of the circu-
lation possess distinct morphological and physiological
characteristics. For many years, it was thought that blood
flow was responsible for establishing vascular identity,
triggering the development of associated architectural
specializations. This view was changed in the late 1990s
when two groups showed that ephrinB2 and its receptor,
EphB4, were cell surfacemarkers of arteries and veins, re-
spectively, and that they were expressed before the onset
of blood flow (Adams et al., 1999; Wang et al., 1998).
These data demonstrated that arterial and venous specifi-
cation in the developing embryo can be genetically pre-
determined. Additionally, interactions between arterial
ephrinB2 and venous EphB4 are required for vascular
development, since mice deficient in either molecule do
not undergo angiogenesis.evelopmental Cell 12, February 2007 ª2007 Elsevier Inc. 183
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pathways upstream of ephrinB2 expression, particularly
during dorsal aorta formation (Figure 3). Sonic hedgehog
derived from the notochord and floor plate induces VEGF
expression in adjacent somitic tissue. VEGF-Aupregulates
Notch pathway components, including Notch-1 and its
ligand, Delta-like-4, in nearby endothelial cells (Duarte
et al., 2004; Lawson et al., 2001; Lawson et al., 2002),
which, inmice, occurs through the activity of the transcrip-
tion factors Foxc1 and Foxc2 (Seo et al., 2006). Localiza-
tionof bothNotchandNotch ligands in theendothelial cells
themselves suggest a juxtacrine signaling mechanism,
which eventually leads to the expression of the bHLH tran-
scription factors gridlock (zebrafish) and hesr1/hesr2
(mice) (Kokubo et al., 2005; Zhong et al., 2001). Animals
missing any of the genes discussed above or both of the
Notch effector genes, Hey1 and Hey2 (Fischer et al.,
2004), show defective ephrinB2 expression and arterial
development while venous specification is generally unaf-
fected. Strikingly, both copies of the Delta-like-4 gene are
required; haploinsufficient mice display lethality due to
arterial vascular abnormalities (Duarte et al., 2004; Gale
et al., 2004; Krebs et al., 2004). These and other experi-
ments that alter Notch activity have emphasized the
importance of vessel identity. Arteriovenous malforma-
tions develop when Notch signaling is either reduced
(Krebs et al., 2004) or constitutively active (Carlson et al.,
2005) in endothelial cells, likely a result of EphB4 or
ephrinB2 misexpression leading to defective boundary
formation.
Discovery of arterial specification pathways gave
rise to the idea that venous development is the default
state, while arteries arise in the presence of active
signaling events. This idea was later challenged when
COUP-TFII, an orphan nuclear receptor, was shown to
be an active vein specification factor (You et al.,
2005). Genetic ablation of this molecule resulted in the
arterialization of veins, and its ectopic expression could
suppress Neuropilin-1 expression and Notch signaling
usually active in arterial cells. Histology of the trans-
formed veins noted the presence of hematopoietic
clusters appearing to bud from the endothelial layer, a
feature usually attributed to arterial vessels. In future ex-
periments, it will be interesting to elucidate this pathway
and determine its complexity in comparison to arterial
differentiation.
Despite recent focus on the genetic programs that de-
termine vessel identity, modern techniques have also
been used to address the impact of blood flow on endo-
thelial cell differentiation. Engraftment experiments have
shown that avian vascular identity is reversible during
the embryonic period, suggesting a role for the microenvi-
ronment (Moyon et al., 2001). Time-lapse analysis reveals
that this vascular plasticity is physiologically important
during angiogenesis within the yolk sac vascular tree. As
to laminar stress, eliminating blood flow in this tissue inter-
rupted arterial differentiation, and its reversal transformed
arteries into veins in terms of marker expression (le Noble
et al., 2004). Thus, endothelial cells are plastic in some184 Developmental Cell 12, February 2007 ª2007 Elsevier Inc.cases and can respond to shear stress cues to further
refine their differentiation status.
Endothelial-Derived Signals Support Organ
Development and Function
Given the ubiquitous presence of vascular networks and
their importance in tissue survival, it is not surprising that
they have acquired functions in addition to oxygen and
nutrient transport (Figure 4) (Cleaver, 2004). Close associ-
ations between vessels and developing organs have been
observed for many years, suggesting the possibility that
they can provide inductive signals. Testing such hypothe-
ses is complicated by the fact that loss-of-function
observations could be due to the interruption of blood
flow. Several studies have circumvented this problem by
making observations during development, before the on-
set of blood flow, as well as by utilizing in vitro methods.
Heart
Studies of heart development gave the first evidence of re-
ciprocal interactions between endothelial and surrounding
tissue during development. The myocardial layer fails to
mature in the absence of endothelium (Stainier et al.,
1995). Endocardial cells produce neuregulin, which binds
to ErbB2 and B4 on adjoining myocardium, inducing tra-
beculation of this cell layer, enabling heart contractility
(Kramer et al., 1996; Meyer and Birchmeier, 1995). Con-
versely, signals from the myocardium including TGF-
beta (Brown et al., 1999; Dor et al., 2001) and VEGF (Dor
et al., 2001) are required to induce the endothelial-mesen-
chymal transition of endocardial cells that precedes valve
formation.
Figure 3. Model for Arterio-Venous Specification in the Axial
Vessels of the Developing Embryo
Sonic hedgehog secreted by the notochord and floorplate induces
VEGF production by adjacent somites. VEGF arterializes the dorsal
aorta, inducing Notch-1 and Delta-like-4 expression through a mecha-
nism involving the transcription factors Foxc1 and Foxc2. Notch sig-
naling and downstream effectors promote expression of the arterial
marker ephrinB2 and inhibit the venous marker EphB4. In the cardinal
vein, COUP-TFII is required for strong EphB4 expression and venous
differentiation through inhibition of the Neuropilin and effectively the
downstream Notch pathway.
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Influence Organ Development and
Function
Several examples exist describing the direct
impact of endothelial cells on different pro-
cesses in embryonic and adult tissue.Interactions between Endothelial Cells and the
Hematopoietic System
In addition to sharing a common precursor, hematopoietic
cells extensively interact with endothelial cells from the
earliest embryonic stages onward. During development,
hematopoietic colonies are localized first in extraembry-
onic yolk sac blood islands before appearing in the
aorta-gonad-mesonephrous (AGM) region of the embryo
and the placenta (Gekas et al., 2005; Ottersbach and
Dzierzak, 2005). At this time, hematopoietic cells appear
to bud from aortic vessels, suggesting that endothelial
cells support hematopoietic stem cell (HSC) genesis. Ge-
netic labeling experiment confirmed that some cells with
HSC activity, meaning the ability to completely reconsti-
tute lethally irradiated recipients, can be derived from
the endothelial cell layer (de Bruijn et al., 2002). These
newly born HSCs populate the fetal liver and eventually
home to the bonemarrow, which is themajor site of hema-
topoiesis throughout adult life.
It has been proposed that, in the adult bone marrow,
sinusoidal endothelial cells influence HSC function. Endo-
thelial cells isolated from hematopoietic regions of the
embryo have the ability to support HSCs in vitro (Li et al.,
2003; Ohneda et al., 1998). Furthermore, in situ localiza-
tion using a novel HSC subtype marker, CD150, found
that this cell population is located adjacent to the sinusoi-
dal vasculature. These observations have prompted the
recognition of a potential vascular niche, in addition to
the well-described endosteal (bone) surface, as a micro-
environment that supports stem cell activity (Kiel et al.,
2005). There is evidence that the vascular niche regulates
other progenitor populations. In vitro, bone marrow endo-
thelial cells boost the survival and maturation of megakar-
yocytes in a contact-dependent manner. In addition, the
residual thrombopoiesis detected in thrombopoietin-
deficient mice is greatly enhanced by the administration
of CXCL12 (SDF-1) and FGF4, a treatment that functions
by localizing megakaryocytes to the vascular niche
(Avecilla et al., 2004).The close relationship between endothelial and hema-
topoietic cells is further supported by cell lineage studies.
Derivation of hematopoietic cells from murine embryonic
stem cells may include an intermediate hemangioblastic
stage (Kennedy et al., 1997), while humanHSCs can incor-
porate into the vasculature of most murine tissues, with
the exception of brain (Bailey et al., 2004). In a quail-chick
parabiosis model, HSCs were able to generate several
nonhematopoietic cell types, including endothelial cells,
smooth muscle, and adventitial tissues (Zhang et al.,
2006). Adult murine bone marrow-derived stem cells can
also contribute to choroidal neovascularization. In this
model, HSC differentiation was not the result of cell fusion,
but rather a result of their ability to adopt an endothelial
fate (Sengupta et al., 2003). The two cell types also share
regulatory mechanisms, as cytokines and growth factors
involved in the maintenance/differentiation of hematopoi-
etic lineages also affect endothelial cells. For example,
granulocyte macrophage colony stimulating factor (GM-
CSF), a cytokine that drives HSCs and progenitor cell dif-
ferentiation, induces angiogenesis in a chick chorioallan-
toic membrane (CAM) assay through activation of the
Jak2/Stat3 pathway (Valdembri et al., 2002). In total, cur-
rent evidence suggests that endothelial cells and hemato-
poietic cells functionally complement each other during
both embryonic and adult life.
Induction of Endoderm-Derived Tissues
Liver development begins when a portion of the ventral
foregut endoderm is specified as hepatocyte primordium,
exhibiting a columnar epithelial appearance at e8.5
(Zaret, 2002). This region lies adjacent to primitive
endothelial cells that express VEGFR2, located within
the septum transversum mesenchyme. As development
progresses following e9.5, the endodermal epithelial cells
divide and invade the mesenchyme, intermixing with res-
ident endothelial cells and their associated hematopoietic
colonies. Using mice genetically deficient in endothelial
cell lineages (flk-1-deficient), it was established that endo-
thelial cell-derived signals promote hepatic endodermDevelopmental Cell 12, February 2007 ª2007 Elsevier Inc. 185
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2001). In these mice, hepatic endoderm within the liver
bud proliferated, but the cells never expanded into the ad-
jacent tissue. In vitro explants of the e9.5 liver bud from
wild-type mice formed a vascular network and supported
growth of albumin-positive cells after 72 hr in culture. He-
patic outgrowth was severely blunted in the absence of
endothelial cells in explants from either flk-1mice or those
treated with an inhibitor of angiogenesis.
The endothelial-derived signals leading to hepatocyte
differentiation and migration have not been identified.
Clues may come from experiments performed in adult
tissues, where VEGF-A increases hepatocyte growth by
stimulating the sinusoidal endothelium to produce HGF
(LeCouter et al., 2003c). This activity reduced liver dam-
age in mice exposed to a hepatotoxin. Thus, endothelial-
derived HGF is a candidate regulator of liver organogene-
sis in the developing embryo.
The thyroid also appears to respond to arterial vascular
cues during development independent of blood flow.
However, instead of regulating early budding from the
pharyngeal epithelium, endothelial cells control position-
ing of the thyroid primordium during developmental reloc-
alization. The thyroid was misplaced in both zebrafish and
mouse mutants with defective vessel development. In ad-
dition, ectopic localization of endothelial cells influenced
thyroid localization. Identifying nearby vessels suggested
a mechanism by which arterial vessels, or an associated
cell type, produce attractive guidance signals that act on
the thyroid primordial organ (Alt et al., 2006).
The pancreas is another endodermal tissue that de-
velops in close apposition to blood vessels (Field et al.,
2003a; Lammert et al., 2001; Pictet et al., 1972). Isolated
murine dorsal endoderm only gives rise to insulin secret-
ing cells in culture when aortic explants are present (Lam-
mert et al., 2001). In addition, dissection of the dorsal aorta
from Xenopus embryos abolishes the expression of the
pancreatic-specific genes NeuroD, Pax6, and insulin
(Lammert et al., 2001). Conversely, hypervascularization
through ectopic VEGF expression in this region leads to
excess pancreatic tissue and ectopic insulin expression.
Using flk-1/ mice that lack endothelial cells, Yoshitomi
and Zaret corroborated these findings and showed that
vascular cells have distinct interactions with dorsal and
ventral pancreatic buds. In the absence of endothelial
cells, the dorsal endoderm expresses Pdx1, a pancreatic
specification transcription factor, but fails to induce the
transcription factor Ptf1a (Yoshitomi and Zaret, 2004).
Interestingly, Ptf1a induction was normal in the ventral
pancreatic buds of flk-1/ mice, although expression of
glucagon was still affected. These differences may be
due to the fact that the dorsal mesoderm is adjacent to ar-
terial vessels while the ventral bud develops near veins. It
will be interesting to determine whether the two vascular
compartments produce factors that differentially affect
organ development.
The presence of isl-1-positive mesenchymal tissue is
also required for pancreatic specification and morpho-
genesis (Ahlgren et al., 1997), potentially through an186 Developmental Cell 12, February 2007 ª2007 Elsevier Inc.FGF10-dependent mechanism (Jacquemin et al., 2006).
In fact, coculture experiments and analysis of flk-1/
mice demonstrate that growth and survival of the mese-
chyme itself (and consequently pancreatic development)
depends on the presence of the dorsal aorta (Jacquemin
et al., 2006). Thus, vascular cells also participate in pan-
creatic development indirectly through ensuring stromal
survival. At later stages in development, one report as-
signs a circulation-dependent effect of the vasculature
on dorsal pancreatic mesenchyme. N-cadherin-deficient
mice display defects in pancreatic budding that can be
rescued by restoring blood flow by expressing the gene
specifically in heart tissue (Esni et al., 2001). Blood flow
provides a source of sphingosine-1-phosphates that are
required for dorsal mesenchyme survival and prolifera-
tion and, therefore, necessary for pancreatic budding
(Edsbagge et al., 2005).
Endothelial cells may also support pancreatic function
in the adult.Within islets, the vasculature is the only source
of the extracellular matrix proteins laminin a4 and a5 and
collagen IV a1 and a2. In vitro, beta cell insulin production
was increased in the presence of these ECM proteins. In
addition, insulin production in mice is decreased when
islet vascular density is reduced through pancreatic-
specific ablation of VEGF-A (Nikolova et al., 2006). Thus,
vascular-derived ECM proteins may function in the main-
tenance of particular islet cell functions. Taken together,
current evidence supports a model in which the vascula-
ture is involved in pancreatic development and mainte-
nance at multiple stages involving interactions with multi-
ple important tissue types with aspects dependent and
independent of blood flow.
Given the different model systems utilized for studying
developmental biology including zebrafish, chicks, Xeno-
pus, and mice, one should use caution in extrapolating
information across species. For example, zebrafish con-
taining the clochemutation lack endothelial cells, but liver
and pancreas development appears to proceed normally
(Field et al., 2003a, 2003b), contrasting with the informa-
tion reported in other species. However, cloche mutants
show similar requirements for endothelial cells in the kid-
ney. These mutants lack proper maintenance of podocyte
function within the glomerulus (Majumdar andDrummond,
1999). Similarly, recession of glomerular capillaries
through deletion of one VEGF-A allele within podocytes
is coincident with the effacement of podocyte foot pro-
cesses (Eremina et al., 2003).
Endothelial Cells and Neural Tissue
In addition to acquiring vascularization, many tissuesmust
also become innervated to function properly. To permeate
tissues, neurons and blood vessels share the strategy of
forming branching networks, and, in some locations, the
two cell types migrate along strikingly similar paths (re-
viewed in Carmeliet and Tessier-Lavigne, 2005). There is
evidence that this results from reciprocal chemotactic sig-
nals between the two tissue types. During development,
vascular smoothmuscle cells produce Artemin and neuro-
trophin-3, which attract sympathetic neuronmigration, re-
sulting in the close spatial relationship between the two
Developmental Cell
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versely, vessels in the skin follow resident sensory nerves
even when the neurons are off track, and, in their absence,
fail to undergo arterial differentiation (Mukouyama et al.,
2002). In this location, neurons produce VEGF, which
may function to attract endothelial cells. Neuron-derived
VEGF is required for arterialization of neighboring vessels
in a feedback loop that requires endothelial expression of
neuropilin-1 (Mukouyama et al., 2005).
In the central nervous system, endothelial cells may be
important modulators of stem cell activity. Anatomical
observations have placed neural stem cells in close appo-
sition to theendothelium,promptingspeculationofacoop-
erative interaction. Coculture experiments demonstrated
that endothelial cells dramatically affected the composi-
tion of embryonic neural stem cell cultures (Shen et al.,
2004). The presence of endothelium increased stem cell
self-renewal through a Notch and Hes1 pathway (Shen
et al., 2004). Interestingly, upon removal of the endothelial
cells, neuron differentiation was increased when com-
pared to monoculture controls. In the songbird brain,
studies point to a role for the endothelium in stimulating
the neural recruitment that leads to seasonal expansion
of the higher vocal center in canaries. In the adult forebrain,
testosterone initiates a signaling loop that upregulates
VEGF expression, ultimately stimulating local angiogene-
sis. The newly formed vessels increase BDNF production,
stimulating the migration of neurons located within the
ventricular zone (Louissaint et al., 2002). The result is a go-
nadal hormone-regulated systemwhere the vasculature is
intimately involved in modulating seasonal avian behavior.
Tissue-Specific Signals Specialize
Different Vascular Beds
As different organs have specific needs in terms of nutrient
requirements and transport, the vasculature can take on
a variety of unique phenotypes. Microarray analyses dem-
onstrate that endothelial cells from different tissue sour-
ces vary at the transcriptional level (Chi et al., 2003). In
transplantation studies, tissue-specific gene expression
in endothelial cells was found to be induced by the organ
microenvironment (Aird et al., 1997). In vivo screening of
phage-displayed peptide libraries has shown consider-
able differences among blood vessels of different organs,
both in normal and pathological circumstances (Ruoslahti,
2004). A proteome-based approach has identified tissue-
specific patterns of endothelial cell surface proteins (Oh
et al., 2004), raising the possibility that such diversity
may be exploited therapeutically or diagnostically.
Common morphological differences among the endo-
thelia of different vascular beds include cell size and
shape, extent of mural cell coverage, and capillary bed
permeability (Simionescu and Simionescu, 1988). For ex-
ample, endocrine organs such as the adrenal gland, pitu-
itary, and pancreas often have fenestrated capillaries that
contain pores sometimes lined with thin diaphragms.
These structures are thought to allow increased transport
of long-range hormones between extravascular cells and
blood (Simionescu and Simionescu, 1988). In fact, elimi-Dnating fenestrations in pancreatic islets diminishes the
ability of mice to mount a wild-type response to glucose
challenge, although glucose regulation is not completely
lost (Brissova et al., 2006; Lammert et al., 2003). Addition-
ally, a loss of fenestrations in the liver is associated with
faulty lipid uptake (Carpenter et al., 2005).
VEGF appears to be an important regulator of vascular
fenestrations. Inhibitors of VEGF signaling pathways de-
crease the presence of fenestrated endothelium in multi-
ple organs, including pancreatic islets and the kidney
(Gerber et al., 1999; Kamba et al., 2006). Ectopic expres-
sion of VEGF induces their presence in vessels that are not
normally fenestrated (Roberts and Palade, 1995). In fact,
early observations noted persistent expression of VEGF
in adult tissues only in epithelial cells associated with fen-
estrated vessels (Breier et al., 1992). As to themechanism,
VEGF signaling may contribute to a fenestrated pheno-
type by stimulating internalization of the cell-cell adhesion
molecule, VE-cadherin (Gavard and Gutkind, 2006).
In contrast to the fenestrated vascular beds present in
high-transport organs, capillaries that directly contact
neural and ocular tissue are linked by extensive tight junc-
tions that restrict transendothelial movement. Accord-
ingly, the cells express increased levels of regulatory
transporters, for example, GLUT-1, LAT-1, and EAAT1-3.
This phenotype is thought to protect against potentially
harmful effects, and, in the brain, it is referred to as the
blood-brain barrier (Abbott et al., 2006). Many studies
have focused on the cell types within the central nervous
system that regulate this barrier. Experiments, primarily
in vitro models, assign functions to astrocytes, neurons,
and pericytes. Currently, much of the evidence involves
astrocytes, which develop perivascular endfeet that
wrap the neural microvasculature. This cell type can in-
duce the blood-brain barrier phenotype via TGFb (Tran
et al., 1999) and angiopoetin-1 (Lee et al., 2003) secretion.
Microarray analysis of PDGF-B and PDGFR-b null mice
demonstrate that vascular pericytes also acquire tissue-
specific qualities. Pericytes located in the brain, but not
in the skin and heart, express specific markers including
the ion channel Kir6.1 (Bondjers et al., 2006).
Perhaps themost dramatically specialized vascular bed
is that located in the uterus of placental mammals during
pregnancy (Red-Horse et al., 2004). In animals that exhibit
hemochorial placentation (humans, rodents), fetal tropho-
blast cells from the placenta invade the maternal vascula-
ture and replace the endothelial cell layer in a process
called pseudovasculogenesis. The result is a network of
hybrid vessels that funnel blood to and from the placental
space, incorporating it into the uterine circulation for the
purpose of maternal-fetal exchange. In humans, tropho-
blast invasion transforms maternal arterioles into large-
bore, low-resistance vessels, expanding lumen size up
to 1000-fold and vastly increasing blood flow. This vascu-
lar remodeling requires that the cells undergo an epithe-
lial-to-endothelial transition upregulating integrin avb3,
vascular endothelial (VE)-cadherin, (Zhou et al., 1997a,
1997b), and ephrinB2, the latter of which explains
these cells’ tropism for arterioles rather than veinsevelopmental Cell 12, February 2007 ª2007 Elsevier Inc. 187
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amassive lymphangiogenic response in the endometrium,
a tissue that normally lacks lymphatic vessels (Red-Horse
et al., 2006). When invasion is not carried out properly,
trophoblasts are thought to be the source of factors that
negatively influence the maternal vasculature systemi-
cally, which can result in the development of preeclampsia
(Bdolah et al., 2004). This potentially fatal pregnancy
complication presents as a rapid onset of maternal hyper-
tension, proteinuria, and edema and is associatedwith ex-
cess placental production of the soluble form of VEGFR-1
or sFlt-1 (Levine et al., 2004; Maynard et al., 2003) and
endoglin (Venkatesha et al., 2006).
Given the heterogeneity of vascular beds throughout
different organ systems, there have been efforts to identify
tissue-specific angiogenic molecules that function in reg-
ulating local vascular responses. Endocrine gland-vascu-
lar endothelial growth factor (EG-VEGF) is one such mole-
cule, which has VEGF-like activities, but is structurally
unrelated and signals through G protein-coupled recep-
tors rather than tyrosine kinases (LeCouter et al., 2001;
Lin et al., 2002). EG-VEGF was identified for its ability to
stimulate proliferation and migration in endothelial cells
isolated from the adrenal and pancreas, but not those
from other nonendocrine organs. In vivo, EG-VEGF eli-
cited an appreciable angiogenic response in the mouse
ovary, but not the eye, skeletal muscle, or ear (LeCouter
et al., 2001). EG-VEGF mRNA was confined to endocrine
organs in human tissues; however, investigation of its ex-
pression pattern in mice revealed a divergence between
the two species. The murine homolog of EG-VEGF was
highly expressed in the liver and kidney, while its receptors
were detected in endothelial cells of the same organs
(LeCouter et al., 2003a). Thus, in mice EG-VEGF may
regulate tissue-specific vascular biology in nonendocrine
organs. Instead, its homolog, Bv8, (also known as proki-
neticin-2), was expressed at high level in the testis, and
ectopic application stimulated testicular angiogenesis
(LeCouter et al., 2003b). It will be interesting to discover
if other tissue-specific factors exist and whether or how
they might compliment the VEGF pathway.
In addition to regulating vascular function, there is evi-
dence that avascular tissues play an active role in exclud-
ing vessel ingrowth. The most well-characterized of these
regions is the cornea, where in almost all species there is
a complete absence of vascularization. Multiple antiangio-
genic molecules have been localized to the corneal epi-
thelium (Chang et al., 2001); however, only sFlt-1 appears
to be required to maintain the avascular state. Genetic ab-
lation of the receptor lead to corneal neovascularization,
and sFlt-1 treatment reversed the spontaneous corneal
vascularization that occurs in corn1 and Pax6+/ mouse
lines. These data present a physiological role for the solu-
ble VEGF receptor, which appears to function through
blocking VEGF activity (Ambati et al., 2006).
Endothelial Signals and Tumor Growth
Disease states are frequently accompanied by dynamic
changes in the vascular compartment. Endothelial cells188 Developmental Cell 12, February 2007 ª2007 Elsevier Inc.are important first responders to inflammatory insults by
attracting the infiltration of bone marrow-derived cells
(Rosen, 2004). Conversely, leukocytes within inflamed tis-
sue can be powerful angiogenic stimulators. Given this
positive feedback loop, regulatory mechanisms must be
in place, which are unbalanced in situations of chronic in-
flammation (Carmeliet, 2003). Research aimed at treating
cancer through targeting the vasculature has helped in-
crease our understanding of the interactions between
the different cell types within the tumor environment and
how these relationships impact vascular growth and ho-
meostasis (Figure 5).
Stromal Cells Influence Tumor Angiogenesis
The tumor environment is established following the onset
of disregulated cell proliferation. A growing mass of neo-
plastic cells becomes embedded within the adjacent
stroma consisting of a heterogeneous combination of fi-
broblasts, pericytes, and endothelial and hematopoietic
cells, which can make up as much as 90% of the tumor
mass (Weinberg, 2006). Significant progress has been
made in defining how nontransformed cells influence
tumor initiation and growth, including their role during an-
giogenesis.
Cells of hematopoietic lineage heavily influence the tu-
mor vascular compartment in large part by secreting an-
giogenic molecules. Tumor-infiltrating T or B lymphocytes
express significant amounts of VEGF-A (reviewed in
Ferrara, 2004). In a model of HPV16-initiated squamous
cell carcinoma, mast cells (tissue basophils) contribute
to the angiogenic switch that precedes carcinogenesis
by producing molecules such as MMP-9 and the serine
proteases MCP-4 and MCP-6 (Coussens et al., 1999,
2000). Neutrophils have been identified as another major
source of MMP-9 and have a similar activity in a mouse
model of pancreatic islet carcinogenesis (Nozawa et al.,
2006). A bulk of work from many laboratories has estab-
lished that, in multiple cancer models, inhibiting tumor-
associated macrophages decreases tumor growth and
metastasis. Contributing to this effect is their production
of angiogenic factors including VEGF-A, TNF-a, IL-8,
bFGF, andMMP-9. These data agree with the observation
that, in human pathological samples, poor prognosis is
often correlated with a higher number of infiltrating macro-
phages (Lewis and Pollard, 2006).
It has also been proposed that tumor-associated mac-
rophages may differentiate into endothelial cells (Yang
et al., 2004). Coinjection of CD11b+Gr1+ myeloid spleen
cells isolated from tumor-bearing mice boosts tumor
growth and angiogenesis by secreting MMP-9, which
stimulates VEGF release. In these experiments, the au-
thors noted the incorporation of donor cells into the vascu-
lature and that they had the capacity to differentiate into
an endothelial cell phenotype ex vivo. It should be noted,
however, that the contribution of bone marrow-derived
cells to the endothelium remains quite controversial. Ear-
lier studies proposed that circulating endothelial progeni-
tor cells (EPC) may be incorporated into the growing ves-
sel wall in various pathophysiological conditions (Asahara
et al., 1997; Lyden et al., 2001). However, other work
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Stromal Cell Types during Tumor
Angiogenesis
Solid lesions consist of tumor cells enmeshed
with various stromal types, which can include
fibroblasts and hematopoietic and endothelial
cells. These components communicate with
each other and distant tissues (i.e., bone mar-
row) to affect the state of the vasculature
and, as a consequence, tumor growth. Exam-
ples of angiogenic interactions are depicted
in the figure. Cancer-associated fibroblasts
produce CXCL12, which recruits bone mar-
row-derived endothelial progenitor cells. Fi-
broblasts and hematopoietic as well as tumor
cells are an abundant source of angiogenic
molecules such as VEGF family members
(e.g., VEGF-A, VEGF-B, PlGF), FGF, and
MMPs. As discussed in the text, there is sig-
nificant debate in the field regarding the contri-
bution of bone marrow-derived cells to the
endothelial cell layer.(De Palma et al., 2005; Grunewald et al., 2006) concluded
that the percentage of EPCs that are truly incorporated
into a growing vessel wall is low and that the majority of
bone marrow-derived cells homing to the tumor vascula-
ture are adherent perivascular mononuclear cells, which
may locally produce angiogenic factors (reviewed in
Ferrara and Kerbel, 2005).
In addition to hematopoietic cells, fibroblasts can also
contribute to tumorigenesis by producing angiogenic fac-
tors. In VEGF null fibrosarcoma xenografts, fibroblast-
derived VEGF-A promotes tumor angiogenesis and pro-
gression. In this model, the tumor cells recruited stromal
fibroblasts via PDGF-A production (Dong et al., 2004).
Also highlighting the influence of the stroma, Liang et al.
showed that blocking tumor cell-derived VEGF using hu-
man-specific VEGF-neutralizing antibodies is not as effec-
tive as cross-species antibodies in suppressing tumors
that contain fibroblast dense stroma, such as the pancre-
atic cancer cell line HPAC (Liang et al., 2006). In vivo re-
combination experiments demonstrate that cancer-asso-
ciated, but not normal, fibroblasts can promote epithelial
tumor progression. The authors present data suggesting
that CXCL12 contributes to this tumor-enhancing activity
by recruiting EPCs from the blood that participate in ves-
sel formation, in addition to stimulating tumor cell prolifer-
ation directly (Orimo et al., 2005).
ECM Components Modulate the Tumor
Vasculature
Endogenous antiangiogenic factors (see above) derived
from the ECM, including endostatin, tumstatin and can-
statin, have been reported to limit tumor growth in various
animal models (reviewed in Nyberg et al., 2005). Tumor
angiogenesis and progression are reported to be elevated
inmice that lack tumstatin due to inactivation of the type IV
collagen a3 chain. Tumstatin administration reverses thisDeffect without affecting normal angiogenesis, a result
that requires the presence of b3 integrins (Hamano et al.,
2003). The authors implicate MMP-9 as the major protein-
ase responsible for cleaving type IV collagen, because
mice lacking this protein exhibit decreased levels of circu-
lating tumstatin accompanied by increased tumor growth
(Hamano et al., 2003). Interestingly, ECM regulation has
been linked to the critical tumor suppressor, p53. This pro-
tein induces transcription of the matrix synthesizing en-
zyme, alpha(II) collagen prolyl-4-hydroxylase, which leads
to the generation of tumstatin and endostatin. Condi-
tioned media from p53 or alpha(II) prolyl hydroxylase-
expressing cells inhibits endothelial cell growth in vitro
while expression of the latter molecule in tumor cells sup-
presses xenograft tumor expansion (Teodoro et al., 2006).
Thrombospondin-1 (TSP-1) is another angiostatic ECM
component. Xenograft studies in TSP-1-deficient mice
revealed increased tumor growth due to increased cell
proliferation and vascular density as well as decreased
apoptosis (Lawler et al., 2001). TSP-1 regulates MMP-9;
its overexpression decreases this molecule while the op-
posite effect is observed upon its deletion (Rodriguez-
Manzaneque et al., 2001).
Tumor-Associated Endothelial Cells
Signal to Tumor Cells
While a plethora of studies have elucidated the proangio-
genic activities of tumor cells, fibroblasts, and inflamma-
tory cells, relatively little is known about how endothelial
cells affect this environment in a nutrient-independent
manner. Endothelial cells within tumors have unique
gene expression profiles, suggesting that they possess
tissue-specific qualities (St Croix et al., 2000). In a recent
publication, Bandyopadhyay et al. provide evidence that
endothelial cells can modulate metastasis through the
cell-surface expression of DARC, a molecule previouslyevelopmental Cell 12, February 2007 ª2007 Elsevier Inc. 189
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et al., 2006). The authors provide evidence that DARC in-
teracts with tumor cells via KAI1, a tetraspanin cell surface
protein previously identified as a suppressor of prostate
metastasis (Dong et al., 1995). This interaction inhibits
tumor cell proliferation and modulates the senescence
genes TBX2 and p21. In vivo, the presence of KAI1 in-
hibited metastasis in wild-type, but not DARC-deficient,
mice. These studies indicate that, in analogy to the devel-




Much effort has been invested in discovering the mecha-
nistic basis of vascular growth and maintenance for the
purpose of developing targets that limit angiogenesis.
This strategy has produced promising therapies capable
of treating cancer and angiogenic eye disease (Ferrara
and Kerbel, 2005). The first FDA-approved antiangiogenic
agents (bevacizumab, pegaptanib, ranibizumab, sunitinib,
and sorafenib) inhibit the activity of VEGF-A and poten-
tially other members of the VEGF gene family such as
placental growth factor (PlGF), VEGF-B, VEGF-C, and
VEGF-D. Such drugs extend life expectancy in patients
with certain malignancies when used in combination with
chemotherapy (Ferrara and Kerbel, 2005). Anti-VEGF ther-
apy is also beneficial in treating the wet (neovascular) form
of age-related macular degeneration (Brown et al., 2006;
Gragoudas et al., 2004).
Ongoing studies are aimed at further defining the recip-
rocal signals that function during interactions between the
vasculature and its environment with the hope of identify-
ing new targetable pathways. Indeed, inhibiting Notch
activation in endothelial cells by blocking Delta-like 4 re-
duced tumor size in xenograft cancer models. Delta-like
4 inhibitors were additive with anti-VEGF treatments
and, in some cases, were effective against select anti-
VEGF-resistant tumors. Interestingly, these studies have
helped define the effect of this molecule on endothelial
cells at a mechanistic level, information important for pro-
cesses that function during development. Delta-like 4
limits endothelial cell proliferation, favoring differentiation
and maturation, while its blockade results in increased
amounts of immature, nonfunctioning vessels (Noguera-
Troise et al., 2006; Ridgway et al., 2006). Understanding
interactions between endothelial and vascular support
cells is also important. For example, in an animal model,
inhibiting pericytes in addition to endothelial cells was
considerably more efficacious in late-stage tumors than
VEGF inhibition alone (Bergers et al., 2003). These and
other studies highlight the rapid advances occurring in
the field and create enthusiasm for the future of antiangio-
genic therapeutics.
Conclusions and Future Directions
There is much evidence that blood vessels are integral
components of the developing embryo and that endothe-
lial cells can supply inductive signals independent of the
circulation. In addition, interactions between the vascular190 Developmental Cell 12, February 2007 ª2007 Elsevier Inc.system and adult tissues are complex where the endothe-
lial compartment supports tissue-specific functions and
responds to specialization signals. The future challenge
will be to continue identifying the molecular players medi-
ating these activities. Such discoveries could lead to a bet-
ter understanding of how to manipulate processes such
as neural and hematopoietic stem cell growth or to induce
successful therapeutic angiogenesis. Furthermore, we are
only beginning to understand the cells and molecules in-
volved in establishing vessel diversity, which could lead
to the development of tissue-specific angiogenic modul-
ators. In this review, we have focused on information
concerning blood endothelial cells, but a second type,
lymphatic endothelial cells, is also present within most
tissues (Alitalo et al., 2005). Lymphatic endothelial cells
could also supply signals that affect the surrounding mi-
croenvironment during normal and pathological condi-
tions. Little is known about these potential mechanisms,
but recent seminal advances in the lymphatic biology field
have made identifying such activities possible. Future
work will certainly elaborate on many of these issues,
and the results are sure to uncover interesting and exciting
information.
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